This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The company is one of the most profitable companies manufacturing speciality chemicals in India
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
Subscribe To Our Newsletter & Stay Updated
